Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 32

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 32
---
75% of base salary and an increase in target LTIP award value to $1,575,000. In addition, because Ms. Sacco is deemed important to the success of the Company in her new role as CFO/COO and because she is considered a potential successor to the role of CEO of the Company, she was granted a one-time award in the form of an RSU stock grant with a value in the amount of $1,575,000 which will cliff vest after four years. The company does not regularly grant one-time awards and does not expect to do so on a regular basis, but the board felt this was prudent to help retain Ms. Sacco for the next several years. Our 2025 Compensation Program Brief Summary of Compensation Program GOALS OF THE PROGRAM: • To attract, retain and motivate talented management taking competitors’ compensation practices into account; • Reinforce our strategy; • To support achievement of our Company-wide objectives and increase stockholder value; and • Maintain practices that support good governance. ANNUAL CASH INCENTIVE AWARDS: • Our named executive officers earned their annual cash incentive awards through our Annual Incentive Plan (“AIP”) primarily based on the Company’s achievement of pre-determined performance goals related to Net Sales (weighted 50%) and Adjusted AIP EBITDA (weighted 50%), as defined later in the Compensation Discussion and Analysis. • The Company exceeded its Net Sales target and met 99% of its Adjusted EBITDA goals in the very challenging macroeconomic environment. • Pursuant to the 2025 AIP, our named executive officers achieved a bonus payout equal to 98.6% of their target bonus based on the financial performance of the Company. Our plan also allows for an individual adjustment, up or down, based on individual performance as discussed later in Compensation Discussion and Analysis.

| 44 |     | 2025 Proxy Statement | Prestige Consumer Healthcare Inc. |

Executive Compensation

LONG-TERM INCENTIVE AWARDS: • The performance-based orientation of our long-term incentive program is reflected in 75% of our CEO’s targeted value of the long-term incentive award allocated to performance stock units, which are earned based on performance over 3-years. The remaining 25% is delivered in restricted stock units, which vests ratably over 3-years. • Our other named executive officers’ targeted value of the long-term incentive award was allocated 60% to performance stock units and 40% to restricted stock units. •